Sakae Asanuma
InvestorPresident & CEO at Taiho Ventures, LLC · Manager at Normunity Holding · Board director at Werewolf Therapeutics
Find your path to Sakae
11 people in our graph share verified history with Sakae — schools, employers, funds. One of them is your warm intro.
About
Founding President of Taiho Ventures (2016). Previously President & CEO at Astellas Venture Management and US Head of Astellas Innovation Management, and earlier worked at Yasuda Enterprise. Has invested in over 60 biotech companies, many reaching IPO or M&A.
Contact· self-published, not guessed
Manager at Normunity Holding
Intro paths
In turn, Sakae can intro founders to Normunity Holding's investors below.
Normunity Holding's investors · 1
Board director at Werewolf Therapeutics
Intro paths
In turn, Sakae can intro founders to Werewolf Therapeutics's investors below.
Werewolf Therapeutics's investors · 6
Co-founders at Werewolf Therapeutics
Deals · 2
Normunity HoldingBoard seat
via Taiho Ventures, LLC · filed Jan 2025 · $75M raise
Dren BioBoard seat
via Taiho Ventures, LLC · filed Mar 2022 · $80M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Taiho Ventures, LLC
Frequently asked questions
- Who is Sakae Asanuma?
- Founding President of Taiho Ventures (2016). Previously President & CEO at Astellas Venture Management and US Head of Astellas Innovation Management, and earlier worked at Yasuda Enterprise. Has invested in over 60 biotech companies, many reaching IPO or M&A.
- Where does Sakae Asanuma work?
- Sakae Asanuma is President & CEO at Taiho Ventures, LLC and Manager at Normunity Holding and Board director at Werewolf Therapeutics.
- What boards does Sakae Asanuma sit on?
- Sakae Asanuma holds tracked board seats at Dren Bio, Normunity Holding.